Lebanon City Council approves water plan for Lilly project
The Lebanon City Council on Monday night approved an agreement that would reserve water and wastewater for a $2.1 billion Eli Lilly and Co. development in Boone County.
Eli Lilly and Co.
Articles
Lilly to acquire Boston-based gene therapy firm for $487M
The Indianapolis-based drugmaker said it has reached a definitive agreement to acquire Akouos Inc., a seven-year-old biotech firm, which is running early clinical trials for its lead therapy for hearing loss.
Coronavirus variant swarm could fuel winter surge
Any variant that winds up dominating in coming months will probably challenge a key line of treatment and protection for people with compromised immune systems—the drugs known as monoclonal antibodies.
Suit accuses Lilly of illegally deducting funds from paychecks for vehicle use, extra time off
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
Going strong: U.S. dollar gained value against key currencies in past year
When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
Lilly lands Fast Track designation for potential blockbuster drug
Indianapolis-based Eli Lilly and Co. announced Thursday that it has received a Fast Track designation from the U.S. Food and Drug Administration to investigate its diabetes drug tirzepatide for the treatment of adults with obesity.
Q&A: Career path jumps from megacorp to small not-for-profit
Michele Sawyer started Sept. 1 as chief financial officer at the Indiana Biosciences Research Institute after more than two decades at drugmaker Eli Lilly and Co. and its animal health spinoff, Elanco Animal Health.
Indy Chamber exec joins developer working on Boone County innovation district
Ian Nicolini, who has served as Indy Chamber’s chief operating officer since October 2020, is leaving his position to join a commercial real estate developer working to recruit businesses to a high-tech research district planned in Boone County.
Insulin cap for Medicare patients signals hope for others
In January, the cost of insulin for patients on Medicare will be capped at $35 a month. But that cap doesn’t apply to those with private insurance, which is used by the majority of those in need of insulin.
Editorial: Impact of abortion ban demands review
Indiana ended up with a rushed law that seemed to please few.
Why did major Indiana companies stay silent on new abortion law—until it passed?
Despite negative impacts, Indiana’s largest employers didn’t weigh in publicly on the state’s new abortion law while it was being debated.
Republicans block cap on patient insulin costs
GOP lawmakers had earlier tried to offer their own, more scaled-back version of an insulin price limit, but Democrats rejected it as too narrow.
In wake of new abortion ban, Lilly says it will look outside Indiana for expansion projects
Indianapolis-based Eli Lilly and Co. said Indiana’s new abortion law could hinder its ability to attract diverse scientific, engineering and business talent to the state.
Jury orders Lilly to pay $61M in whistleblower Medicaid fraud case
The cost to Indianapolis-based Eli Lilly and Co. would reach more than $183 million because cases brought under the False Claims Act triple the final judgment. Lilly said it plans to appeal and is confident that it will prevail.
Lilly Q2 profit slumps 33% as older products lose steam
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
Lilly Endowment sells more than $500 million in Eli Lilly stock
The stock sale is a primary way for the endowment, one of the largest private philanthropic foundations in the United States, to raise cash to make grants to arts, education, religious and community development organizations.
Lilly overtakes larger rival Pfizer in market cap as shares continue to soar
Like a kite that has caught a stiff breeze, Eli Lilly and Co. stock is having the ride of its life. Shares in the Indianapolis-based drugmaker have soared 41% in the past 52 weeks, to about $331 each.
Lilly inks $275M deal to supply more COVID-19 antibody
Indianapolis-based Eli Lilly and Co. on Wednesday announced an agreement with the U.S. government to supply an additional 150,000 doses of its COVID-fighting antibody bebtelovimab.
Lilly faces lawsuit over alleged excessive retirement-plan fees
The drugmaker is one of hundreds of U.S. companies being sued in the recent trend in litigation: excessive fees on 401(k) retirement plans.
Lilly whistleblower sues drugmaker, alleging retaliation
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.